Eli Lilly’s stocks fell 1 percent in afternoon trading and Merck and GlaxoSmithKline’s stocks both decreased by more than 2 percent, CNBC reported.
Ms. Pelosi’s plan would allow HHS to negotiate prices on the 250 most expensive drugs, providing they have no more than two competitors. The discounts would then be applied to private health plans across the U.S.
HHS is currently prohibited from negotiating drug prices on behalf of Medicare.
The draft bill, which may be revealed as soon as this week, also includes severe penalties on drugmakers that refuse to participate in negotiations or reach an agreement with the government.
More articles on pharmacy:
Purdue Pharma reaches tentative deal to settle opioid suits dollar opioid settlement
UConn pharmacists’ union seeking to stop prison services change
Generics are getting boxed out of optimal formulary placement: Here’s why
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
